iosBio is a UK-based biotechnology company developing a ground-breaking oral platform that could revolutionize the way vaccines are manufactured, distributed and delivered. Our current focus is an oral vaccine for Covid-19, which has started clinical trials, an oral version of the seasonal influenza vaccine in preclinical studies and several further vaccines and therapies in discovery. We believe that the future of immunization – no needles, no healthcare professionals, no queues and no risk of cross infection – is now possible, and we are working to make it a reality.
250 Monroe Ave NW #400 Grand Rapids, Michigan 49503 United States
4646 E Greenway Rd #100 Phoenix, Arizona 85032 United States